June Sherie Almenoff

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
8 years
Director since
2023

8 years of board service in total across 3 boards, counting each seat separately. Longest: Avalo Therapeutics Inc., 3 years.

3 years · Since 2023
2 years · Since 2024
1 year · Since 2024

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 2, 2026 Actinium Pharmaceuticals Inc. (Delaware) Grant or award +18,000 — —
Nov 18, 2025 Tenax Therapeutics Inc. Open-market purchase +1,900 $7.52 $14,288
Nov 17, 2025 Tenax Therapeutics Inc. Open-market purchase +93 $7.15 $665
Mar 28, 2025 Avalo Therapeutics Inc. Option exercise +3,167 — —
Nov 13, 2024 Avalo Therapeutics Inc. Open-market purchase +500 $13.00 $6,500
Nov 12, 2024 Avalo Therapeutics Inc. Open-market purchase +500 $12.50 $6,250

Questions about June Sherie Almenoff

What boards is June Sherie Almenoff on?

June Sherie Almenoff sits on the boards of Actinium Pharmaceuticals Inc. (Delaware), Avalo Therapeutics Inc. and Tenax Therapeutics Inc.

How long has June Sherie Almenoff served on boards?

Our records show at least 8 years of board service across 3 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.